Why subscribe
Short research notes
Plain-English summaries of new or useful supplement evidence without turning every paper into a product recommendation.
Newsletter archive
The newsletter is for readers who want concise research updates, product-quality reminders, and safety-first supplement context without sales-first ranking language. Use this archive as a preview of the style.
Why subscribe
Plain-English summaries of new or useful supplement evidence without turning every paper into a product recommendation.
Why subscribe
Practical prompts for interactions, stacking, dose form, product quality, and situations where extra caution makes sense.
Why subscribe
Updates when major guides, comparison pages, infographics, and education tools are expanded or refreshed.
Free safety checklist
Join for concise supplement evidence notes, product-quality reminders, and safety-first guide updates.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Research interests
Choose a content lane, then use your email below. Existing subscribers can enter the same address to update their research-interest tag. This records a newsletter content preference only; do not enter symptoms, diagnoses, medications, or other health information.
Free guide
Subscribe or update this email address so future evidence notes can be selected for this research-interest lane.
Archive preview
Medication context, dose transparency, serving-size tricks, and why product form matters before any buying decision.
How to separate human trials, mechanism background, traditional use, mixed findings, and marketing language.
Elemental dose, form differences, digestive tolerance, kidney-health cautions, and why labels can be confusing.
The newsletter focuses on supplement research notes, evidence-quality reminders, safety context, product-quality checks, and updates to major site guides.
Yes. The research-interest selector lets you choose Sleep, Stress, Anxiety, Focus, or General research. It stores a newsletter content preference rather than asking for symptoms or medical details.
No. The newsletter is designed as a research and education update. Any product or affiliate context should remain secondary to evidence, safety, and label-quality discussion.
Yes. Newsletter emails should include an unsubscribe option, and the privacy page explains how email subscriptions are handled.
Tool context
Join The Hippie Scientist newsletter for evidence-first supplement notes, safety checklists, product-quality reminders, and plain-English research updates. Tool and utility pages are meant to support research decisions, not replace the full evidence review. Use the results as a triage layer that points you toward the profile, guide, or safety topic that deserves closer reading.
For Evidence-first supplement notes, without the hype cycle., the most useful approach is conservative: check one question at a time, compare the result against the full profile, and avoid assuming that an automated output proves safety, effectiveness, or correct dosing.
If the question involves prescription medications, pregnancy, breastfeeding, chronic disease, surgery, addiction risk, or a child, the next step should include a clinician or pharmacist rather than relying only on a supplement website.